Aisling Capital Management as of June 30, 2021
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 21 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 59.2 | $370M | 6.1M | 60.96 | |
| Elevation Oncology (ELEV) | 6.2 | $39M | 2.8M | 13.57 | |
| Monte Rosa Therapeutics (GLUE) | 5.4 | $33M | 1.5M | 22.70 | |
| Harmony Biosciences Hldgs In (HRMY) | 3.8 | $24M | 843k | 28.23 | |
| Nuvation Bio Com Cl A (NUVB) | 3.8 | $24M | 2.5M | 9.31 | |
| Syndax Pharmaceuticals (SNDX) | 2.8 | $18M | 1.0M | 17.17 | |
| Spruce Biosciences (SPRB) | 2.2 | $14M | 1.2M | 11.21 | |
| Biomea Fusion (BMEA) | 2.0 | $13M | 799k | 15.61 | |
| Aeglea Biotherapeutics | 1.9 | $12M | 1.7M | 6.96 | |
| Aclaris Therapeutics (ACRS) | 1.8 | $11M | 635k | 17.56 | |
| Poseida Therapeutics I (PSTX) | 1.7 | $11M | 1.0M | 10.02 | |
| Talaris Therapeutics | 1.6 | $10M | 683k | 14.69 | |
| Avrobio Ord (AVRO) | 1.4 | $9.0M | 1.0M | 8.89 | |
| Marker Therapeutics Ord | 1.4 | $8.8M | 3.1M | 2.79 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.4 | $8.7M | 1.3M | 6.54 | |
| Reneo Pharmaceuticals (RPHM) | 1.3 | $8.3M | 886k | 9.33 | |
| Obseva Sa | 0.7 | $4.2M | 1.4M | 3.03 | |
| Atreca Cl A Com (BCEL) | 0.5 | $3.3M | 388k | 8.52 | |
| Viracta Therapeutics (VIRX) | 0.5 | $3.3M | 289k | 11.34 | |
| Zosano Pharma Corporation Com New | 0.4 | $2.6M | 2.7M | 0.95 | |
| Nabriva Therapeutics SHS | 0.0 | $258k | 191k | 1.35 |
